BRCA1 and ovarian serous adenocarcinoma: Although the exact relationship between DYNLL1 and the 53BP1 axis is still unclear [119,120], loss of DYNLL1 was associated with PARPi resistance in a panel of patient-derived BRCA1-mutant high-grade serous ovarian cancer lines [54].